Related Experiment Video
Updated: Feb 7, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
10.7K
Hereditary Alpha Tryptasemia: Genotyping and Associated Clinical Features
1Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 11N240 MSC 1889, 10 Center Drive, Bethesda, MD 20892, USA.
Immunology and Allergy Clinics of North America
|July 16, 2018
Summary
Hereditary alpha tryptasemia is a genetic condition linked to the TPSAB1 gene. Higher gene copy numbers correlate with increased tryptase levels and symptom severity, offering insights into potential therapies.
Area of Science:
- Genetics
- Biochemistry
- Immunology
Background:
- Hereditary alpha tryptasemia is an autosomal dominant genetic trait.
- It is caused by increased germline copies of the TPSAB1 gene, which encodes alpha-tryptase.
- Individuals with this trait exhibit elevated basal serum tryptase levels.
Purpose of the Study:
- To investigate the relationship between TPSAB1 gene copy number and serum tryptase levels.
- To explore the correlation between tryptase levels and the severity of multisystem complaints.
- To understand the implications for potential therapeutic strategies.
Main Methods:
- Genetic analysis to determine TPSAB1 germline copy number.
- Measurement of basal serum tryptase levels.
- Clinical assessment of multisystem complaints.
Main Results:
- A gene-dose relationship exists between TPSAB1 copy number and basal serum tryptase levels.
- Higher tryptase levels are correlated with increased symptom severity.
- The number of alpha-encoding TPSAB1 copies directly influences both tryptase levels and clinical presentation.
Conclusions:
- Elevated basal serum tryptase due to hereditary alpha tryptasemia is linked to TPSAB1 gene dosage.
- Understanding this gene-dose effect is crucial for managing associated multisystem symptoms.
- Further research into the functional effects of tryptase may reveal new therapeutic targets.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K
01:26Esophageal Strictures-II: Clinical Features and Management
680
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
680
01:25Endocarditis II: Clinical Features of Infective Endocarditis
535
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
535
01:19Pericarditis II: Clinical Features and Diagnostic Tests
341
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
341
01:28Esophageal Varices-II: Clinical Features and Management
597
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
597
01:27Myocarditis II: Clinical Features and Diagnostic Tests
332
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
332